Log in | Register

Is the literature inconclusive about the harm from HES? Yes

Christian Ertmer| Djillali Annane| Philippe Van Der Linden
Editorial
Volume 43, Issue 10 / October , 2017

Pages 1520 - 1522

No abstract available.

References

  1. Vincent JL (2010) We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 38(10 Suppl):S534–S538
    • View reference on publisher's website
    • View reference on PubMed
  2. Latta T (1832) Malignant cholera: documents communicated by the Central Board of Health, London, relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins. Lancet 18:274–277 (originally published as Vol 2, Issue 457)
    • View reference on publisher's website
  3. Birtwhistle R (1832) Treatment of malignant cholera at Leeds. Lancet 18:671–672 (originally published as Vol 2, Issue 469)
    • View reference on publisher's website
  4. M‘Cabe J (1832) The treatment of cholera: by the injection of saline solutions into the veins, not warranted by the pathological condition of the blood. Lancet 18:528–529 (originally published as volume 2, issue 465)
    • View reference on publisher's website
  5. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H (2009) Hydroxyethyl starches: different products–different effects. Anesthesiology 111:187–202
    • View reference on publisher's website
    • View reference on PubMed
  6. Shum HP, Lee FM, Chan KC, Yan WW (2011) Interaction between fluid balance and disease severity on patient outcome in the critically ill. J Crit Care 26:613–619
    • View reference on publisher's website
    • View reference on PubMed
  7. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, Kellum JA, Mythen MG, Shaw AD, ADQI XII Investigators Group (2014) Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 113:740–747
    • View reference on publisher's website
    • View reference on PubMed
  8. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
    • View reference on publisher's website
    • View reference on PubMed
  9. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, 6S Trial Group, Scandinavian Critical Care Trials Group (2012) Hydroxyethyl starch 130/0.42 vs Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134
    • View reference on publisher's website
    • View reference on PubMed
  10. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901–1911
    • View reference on publisher's website
    • View reference on PubMed
  11. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB (2009) Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 37:1275–1281
    • View reference on publisher's website
    • View reference on PubMed
  12. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, Preiser JC, Outin H, Troché G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec’h C, Cousson J, Thibault L, Chevret S, CRISTAL Investigators (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817
    • View reference on publisher's website
    • View reference on PubMed
  13. Jacob M, Fellahi JL, Chappell D, Kurz A (2014) The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care 18:656
    • View reference on publisher's website
    • View reference on PubMed
  14. Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, Pearse RM (2014) Incidence of postoperative death and acute kidney injury associated with i.v. 6 % hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 112:25–34
    • View reference on publisher's website
    • View reference on PubMed
  15. Raiman M, Mitchell CG, Biccard BM, Rodseth RN (2016) Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: a systematic review and meta-analysis. Eur J Anaesthesiol 33:42–48
    • View reference on publisher's website
    • View reference on PubMed
  16. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A (2013) Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 118:387–394
    • View reference on publisher's website
    • View reference on PubMed
  17. Van Der Linden P, James M, Mythen M, Weiskopf RB (2013) Safety of modern starches used during surgery. Anesth Analg 116:35–48
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement